undamentalytics Newsletter
Sign in

Atyr Pharma Inc balance sheet

At the end of fiscal 2025, Atyr Pharma Inc had total assets of $93.0m and shareholders' equity of $67.5m. It held $10.7m in cash against $0 of debt: net cash of $10.7m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents917210231111
Total current assets3236114811038280
Total assets3639116961219793
Accounts payable1113444
Deferred revenue (current)0——————
Total current liabilities136614161515
Short-term debt9——————
Total debt11000000
Shareholders' equity213210971917067
Net debt (negative = net cash)2−17−2−10−23−11−11
Shares outstanding———59m63m84m98m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ATYR vs CLNNATYR vs CLDXATYR vs CRVO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Atyr Pharma Inc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Atyr Pharma Inc.